Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Polypeptide Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Ipsen PHarma Biotech
SciClone Pharmaceuticals
Lilly
Merck Serono
Novartis
Ferring Pharmaceuticals
Takeda
Asahi Kasei
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Polypeptide Drug Market Overview 2018-2029
-
1.1 China Polypeptide Drug Industry Development Overview
-
1.2 China Polypeptide Drug Industry Development History
-
1.3 China Polypeptide Drug Industry Market Size (2018-2029)
-
1.4 China Polypeptide Drug Market Analysis by Type from Production Side
-
1.4.1 China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Polypeptide Drug Market Analysis by Application from Consumption End
-
1.5.1 China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Polypeptide Drug Market Analysis by Region
-
1.6.1 North China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Polypeptide Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Polypeptide Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Polypeptide Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Polypeptide Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Polypeptide Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Polypeptide Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Polypeptide Drug Industry Development
Chapter 3 Polypeptide DrugIndustry Chain Analysis
-
3.1 Polypeptide Drug Industry Chain
-
3.2 Polypeptide Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Polypeptide Drug Market
-
3.3 Polypeptide Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Polypeptide Drug Market
Chapter 4 China Polypeptide Drug Market, by Type
-
4.1 China Polypeptide Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Polypeptide Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Polypeptide Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Polypeptide Drug Production Volume and Growth Rate of Type 1
-
4.5.2 China Polypeptide Drug Production Volume and Growth Rate of Type 2
-
4.5.3 China Polypeptide Drug Production Volume and Growth Rate of Type 3
Chapter 5 China Polypeptide Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Polypeptide Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Polypeptide Drug Market Size and Growth Rate, by Application
-
5.5.1 China Polypeptide Drug Market Size and Growth Rate of Application 1
-
5.5.2 China Polypeptide Drug Market Size and Growth Rate of Application 2
-
5.5.3 China Polypeptide Drug Market Size and Growth Rate of Application 3
Chapter 6 China Polypeptide Drug Market, by Region
-
6.1 China Polypeptide Drug Production Volume and Production Value, by Region
-
6.2 China Polypeptide Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Polypeptide Drug Market Analysis
-
7.1 North China Polypeptide Drug Market, by Type
-
7.2 North China Polypeptide Drug Market, by Application
Chapter 8 Central China Polypeptide Drug Market Analysis
-
8.1 Central China Polypeptide Drug Market, by Type
-
8.2 Central China Polypeptide Drug Market, by Application
Chapter 9 South China Polypeptide Drug Market Analysis
-
9.1 South China Polypeptide Drug Market, by Type
-
9.2 South China Polypeptide Drug Market, by Application
Chapter 10 East China Polypeptide Drug Market Analysis
-
10.1 East China Polypeptide Drug Market, by Type
-
10.2 East China Polypeptide Drug Market, by Application
Chapter 11 Northeast China Polypeptide Drug Market Analysis
-
11.1 Northeast China Polypeptide Drug Market, by Type
-
11.2 Northeast China Polypeptide Drug Market, by Application
Chapter 12 Southwest China Polypeptide Drug Market Analysis
-
12.1 Southwest China Polypeptide Drug Market, by Type
-
12.2 Southwest China Polypeptide Drug Market, by Application
Chapter 13 Northwest China Polypeptide Drug Market Analysis
-
13.1 Northwest China Polypeptide Drug Market, by Type
-
13.2 Northwest China Polypeptide Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Ipsen PHarma Biotech
-
14.1.1 Ipsen PHarma Biotech Company Profile
-
14.1.2 Ipsen PHarma Biotech Polypeptide Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 SciClone Pharmaceuticals
-
14.2.1 SciClone Pharmaceuticals Company Profile
-
14.2.2 SciClone Pharmaceuticals Polypeptide Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Lilly
-
14.3.1 Lilly Company Profile
-
14.3.2 Lilly Polypeptide Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merck Serono
-
14.4.1 Merck Serono Company Profile
-
14.4.2 Merck Serono Polypeptide Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis Polypeptide Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Ferring Pharmaceuticals
-
14.6.1 Ferring Pharmaceuticals Company Profile
-
14.6.2 Ferring Pharmaceuticals Polypeptide Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Takeda
-
14.7.1 Takeda Company Profile
-
14.7.2 Takeda Polypeptide Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Asahi Kasei
-
14.8.1 Asahi Kasei Company Profile
-
14.8.2 Asahi Kasei Polypeptide Drug Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Polypeptide Drug Industry Research Conclusions
-
15.2 Polypeptide Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Polypeptide Drug Industry Market Size (2018-2029)
-
Figure China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Polypeptide Drug Market Size and Growth Rate from 2018-2029
-
Figure Polypeptide Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Polypeptide Drug Market Share by Type in 2018
-
Figure China Polypeptide Drug Market Share by Type in 2023
-
Figure China Polypeptide Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Polypeptide Drug Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Polypeptide Drug Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Polypeptide Drug Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Polypeptide Drug Market Share by Application in 2018
-
Figure China Polypeptide Drug Market Share by Application in 2023
-
Figure China Polypeptide Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Polypeptide Drug Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Polypeptide Drug Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Polypeptide Drug Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Polypeptide Drug Production Volume by Region (2018-2023)
-
Table China Polypeptide Drug Production Volume Share by Region (2018-2023)
-
Figure China Polypeptide Drug Production Volume Share by Region (2018-2023)
-
Table China Polypeptide Drug Production Value by Region (2018-2023)
-
Table China Polypeptide Drug Production Value Share by Region (2018-2023)
-
Figure China Polypeptide Drug Production Value Share by Region (2018-2023)
-
Table China Polypeptide Drug Sales Volume by Region (2018-2023)
-
Table China Polypeptide Drug Sales Volume Share by Region (2018-2023)
-
Figure China Polypeptide Drug Sales Volume Share by Region (2018-2023)
-
Table China Polypeptide Drug Sales Value by Region (2018-2023)
-
Table China Polypeptide Drug Sales Value Share by Region (2018-2023)
-
Figure China Polypeptide Drug Sales Value Share by Region (2018-2023)
-
Table North China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table North China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure North China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table North China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table North China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table Central China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table Central China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table Central China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table South China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table South China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure South China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table South China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table South China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table East China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table East China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure East China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table East China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table East China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table Northeast China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table Southwest China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Polypeptide Drug Production Volume by Type (2018-2023)
-
Table Northwest China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Polypeptide Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Polypeptide Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Polypeptide Drug Sales Volume Share by Application (2018-2023)
-
Table Ipsen PHarma Biotech Company Profile
-
Table Ipsen PHarma Biotech Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table SciClone Pharmaceuticals Company Profile
-
Table SciClone Pharmaceuticals Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Lilly Company Profile
-
Table Lilly Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Ferring Pharmaceuticals Company Profile
-
Table Ferring Pharmaceuticals Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
Table Asahi Kasei Company Profile
-
Table Asahi Kasei Polypeptide Drug Revenue, Price and Gross (2018-2023)
-
